nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzphetamine—SLC18A2—Synaptic Vesicle Pathway—UNC13A—amyotrophic lateral sclerosis	0.045	0.107	CbGpPWpGaD
Benzphetamine—SLC6A3—nerve—amyotrophic lateral sclerosis	0.0436	0.0825	CbGeAlD
Benzphetamine—SLC6A2—nerve—amyotrophic lateral sclerosis	0.0351	0.0666	CbGeAlD
Benzphetamine—Naftifine—SIGMAR1—amyotrophic lateral sclerosis	0.0338	0.659	CrCbGaD
Benzphetamine—SLC6A3—hindbrain—amyotrophic lateral sclerosis	0.0326	0.0618	CbGeAlD
Benzphetamine—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.0319	0.0603	CbGeAlD
Benzphetamine—SLC18A2—brainstem—amyotrophic lateral sclerosis	0.0247	0.0468	CbGeAlD
Benzphetamine—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.0245	0.0463	CbGeAlD
Benzphetamine—SLC18A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—amyotrophic lateral sclerosis	0.0211	0.0501	CbGpPWpGaD
Benzphetamine—SLC6A3—brainstem—amyotrophic lateral sclerosis	0.0187	0.0354	CbGeAlD
Benzphetamine—POR—medulla oblongata—amyotrophic lateral sclerosis	0.0181	0.0343	CbGeAlD
Benzphetamine—SLC18A2—medulla oblongata—amyotrophic lateral sclerosis	0.0172	0.0326	CbGeAlD
Benzphetamine—SLC6A3—Parkinsons Disease Pathway—ATXN2—amyotrophic lateral sclerosis	0.0166	0.0394	CbGpPWpGaD
Benzphetamine—POR—spinal cord—amyotrophic lateral sclerosis	0.0161	0.0305	CbGeAlD
Benzphetamine—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.0151	0.0286	CbGeAlD
Benzphetamine—SLC18A2—Amine compound SLC transporters—SLC6A1—amyotrophic lateral sclerosis	0.0146	0.0348	CbGpPWpGaD
Benzphetamine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—amyotrophic lateral sclerosis	0.0142	0.0337	CbGpPWpGaD
Benzphetamine—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.014	0.0266	CbGeAlD
Benzphetamine—SLC18A2—nervous system—amyotrophic lateral sclerosis	0.0129	0.0245	CbGeAlD
Benzphetamine—POR—cerebellum—amyotrophic lateral sclerosis	0.0128	0.0242	CbGeAlD
Benzphetamine—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—amyotrophic lateral sclerosis	0.0126	0.0299	CbGpPWpGaD
Benzphetamine—SLC18A2—Neurotransmitter Release Cycle—CHAT—amyotrophic lateral sclerosis	0.0125	0.0298	CbGpPWpGaD
Benzphetamine—SLC18A2—central nervous system—amyotrophic lateral sclerosis	0.0125	0.0236	CbGeAlD
Benzphetamine—SLC18A2—cerebellum—amyotrophic lateral sclerosis	0.0122	0.0231	CbGeAlD
Benzphetamine—SLC6A3—spinal cord—amyotrophic lateral sclerosis	0.0116	0.022	CbGeAlD
Benzphetamine—SLC18A2—Neurotransmitter Release Cycle—SLC6A1—amyotrophic lateral sclerosis	0.0112	0.0266	CbGpPWpGaD
Benzphetamine—ADRA1A—Endothelin Pathways—ECE1—amyotrophic lateral sclerosis	0.0109	0.0259	CbGpPWpGaD
Benzphetamine—SLC18A2—Synaptic Vesicle Pathway—SLC1A3—amyotrophic lateral sclerosis	0.0107	0.0255	CbGpPWpGaD
Benzphetamine—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.0105	0.0199	CbGeAlD
Benzphetamine—POR—brain—amyotrophic lateral sclerosis	0.0104	0.0197	CbGeAlD
Benzphetamine—Tamoxifen—SIGMAR1—amyotrophic lateral sclerosis	0.0103	0.2	CrCbGaD
Benzphetamine—SLC18A2—brain—amyotrophic lateral sclerosis	0.0099	0.0187	CbGeAlD
Benzphetamine—SLC6A2—Amine compound SLC transporters—SLC6A1—amyotrophic lateral sclerosis	0.00985	0.0234	CbGpPWpGaD
Benzphetamine—SLC6A3—nervous system—amyotrophic lateral sclerosis	0.00979	0.0186	CbGeAlD
Benzphetamine—SLC6A3—central nervous system—amyotrophic lateral sclerosis	0.00943	0.0179	CbGeAlD
Benzphetamine—SLC6A2—Monoamine Transport—SLC6A1—amyotrophic lateral sclerosis	0.00935	0.0222	CbGpPWpGaD
Benzphetamine—SLC6A3—cerebellum—amyotrophic lateral sclerosis	0.00922	0.0175	CbGeAlD
Benzphetamine—SLC6A3—Amine compound SLC transporters—SLC6A1—amyotrophic lateral sclerosis	0.00872	0.0207	CbGpPWpGaD
Benzphetamine—SLC6A3—Monoamine Transport—SLC6A1—amyotrophic lateral sclerosis	0.00828	0.0197	CbGpPWpGaD
Benzphetamine—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.0079	0.015	CbGeAlD
Benzphetamine—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.00761	0.0144	CbGeAlD
Benzphetamine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00755	0.0179	CbGpPWpGaD
Benzphetamine—SLC6A3—brain—amyotrophic lateral sclerosis	0.00749	0.0142	CbGeAlD
Benzphetamine—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00743	0.0141	CbGeAlD
Benzphetamine—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.00735	0.0139	CbGeAlD
Benzphetamine—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.00707	0.0134	CbGeAlD
Benzphetamine—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.00691	0.0131	CbGeAlD
Benzphetamine—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.00663	0.0126	CbGeAlD
Benzphetamine—SLC6A2—brain—amyotrophic lateral sclerosis	0.00604	0.0114	CbGeAlD
Benzphetamine—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.00582	0.011	CbGeAlD
Benzphetamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00572	0.0136	CbGpPWpGaD
Benzphetamine—ADRA1A—brain—amyotrophic lateral sclerosis	0.00562	0.0106	CbGeAlD
Benzphetamine—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.00561	0.0106	CbGeAlD
Benzphetamine—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.00559	0.0106	CbGeAlD
Benzphetamine—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.00538	0.0102	CbGeAlD
Benzphetamine—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.00526	0.00996	CbGeAlD
Benzphetamine—SLC6A3—Parkinsons Disease Pathway—CASP9—amyotrophic lateral sclerosis	0.00497	0.0118	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00475	0.0113	CbGpPWpGaD
Benzphetamine—CYP2B6—brain—amyotrophic lateral sclerosis	0.00445	0.00843	CbGeAlD
Benzphetamine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.0044	0.00833	CbGeAlD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00438	0.0104	CbGpPWpGaD
Benzphetamine—Oxaprozin—PTGS2—amyotrophic lateral sclerosis	0.00435	0.0848	CrCbGaD
Benzphetamine—ADRA2A—brain—amyotrophic lateral sclerosis	0.00427	0.00809	CbGeAlD
Benzphetamine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00423	0.00802	CbGeAlD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00423	0.0101	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00387	0.0092	CbGpPWpGaD
Benzphetamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00385	0.00915	CbGpPWpGaD
Benzphetamine—SLC6A2—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.00379	0.00901	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00364	0.00865	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.0036	0.00855	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.0036	0.00855	CbGpPWpGaD
Benzphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00343	0.00815	CbGpPWpGaD
Benzphetamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00343	0.00815	CbGpPWpGaD
Benzphetamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00341	0.00811	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.00336	0.00799	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00336	0.00798	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00324	0.00771	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00321	0.00762	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00297	0.00705	CbGpPWpGaD
Benzphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00292	0.00693	CbGpPWpGaD
Benzphetamine—Phenylbutazone—PTGS2—amyotrophic lateral sclerosis	0.00287	0.0561	CrCbGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00283	0.00673	CbGpPWpGaD
Benzphetamine—SLC6A2—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.00278	0.0066	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00276	0.00655	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00276	0.00655	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00271	0.00643	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00261	0.00621	CbGpPWpGaD
Benzphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.0026	0.00618	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00252	0.006	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.00246	0.00584	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00246	0.00584	CbGpPWpGaD
Benzphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00231	0.00549	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00231	0.00548	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00217	0.00515	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00215	0.0051	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00215	0.0051	CbGpPWpGaD
Benzphetamine—SLC6A2—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.00214	0.00509	CbGpPWpGaD
Benzphetamine—SLC6A3—Parkinsons Disease Pathway—CASP3—amyotrophic lateral sclerosis	0.00209	0.00497	CbGpPWpGaD
Benzphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00205	0.00486	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.002	0.00476	CbGpPWpGaD
Benzphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00196	0.00467	CbGpPWpGaD
Benzphetamine—CYP2B6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00196	0.00466	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00193	0.00459	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00191	0.00454	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.0019	0.00451	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00182	0.00433	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.0018	0.00428	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00177	0.0042	CbGpPWpGaD
Benzphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00175	0.00416	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00174	0.00414	CbGpPWpGaD
Benzphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00174	0.00413	CbGpPWpGaD
Benzphetamine—SLC6A2—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.00167	0.00398	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00164	0.00391	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00164	0.00391	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.00162	0.00385	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00161	0.00383	CbGpPWpGaD
Benzphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00155	0.00368	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.00148	0.00352	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00148	0.00352	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00148	0.00352	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00147	0.00348	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.00136	0.00322	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.00134	0.00318	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00132	0.00314	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00117	0.00279	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00116	0.00276	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00108	0.00256	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00104	0.00247	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000998	0.00237	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000998	0.00237	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000928	0.00221	CbGpPWpGaD
Benzphetamine—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00089	0.00212	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000889	0.00211	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000884	0.0021	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000884	0.0021	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000883	0.0021	CbGpPWpGaD
Benzphetamine—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000877	0.00208	CbGpPWpGaD
Benzphetamine—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000865	0.00205	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000863	0.00205	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000836	0.00199	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000821	0.00195	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000788	0.00187	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.000784	0.00186	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000717	0.0017	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000717	0.0017	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.000703	0.00167	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000672	0.0016	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000672	0.0016	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000655	0.00156	CbGpPWpGaD
Benzphetamine—ADRA1A—AMPK Signaling—TP53—amyotrophic lateral sclerosis	0.000644	0.00153	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000615	0.00146	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000609	0.00145	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000592	0.00141	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000573	0.00136	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000571	0.00136	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000537	0.00128	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—DAO—amyotrophic lateral sclerosis	0.000518	0.00123	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000506	0.0012	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000499	0.00119	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	0.000486	0.00115	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000478	0.00114	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.00047	0.00112	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000464	0.0011	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000453	0.00108	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000421	0.001	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000404	0.00096	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000398	0.000947	CbGpPWpGaD
Benzphetamine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000393	0.000934	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000393	0.000933	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000386	0.000916	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000368	0.000875	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000362	0.000861	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GSR—amyotrophic lateral sclerosis	0.000362	0.000861	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000358	0.000851	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000353	0.00084	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	0.00034	0.000807	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000332	0.000789	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000328	0.00078	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000315	0.000748	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000312	0.000742	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000309	0.000733	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000305	0.000725	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000305	0.000725	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000305	0.000725	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000298	0.000707	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000293	0.000695	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000283	0.000673	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000279	0.000664	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000279	0.000663	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000271	0.000644	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000268	0.000636	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00026	0.000617	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000252	0.000598	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000249	0.000591	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000246	0.000586	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000244	0.00058	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000224	0.000532	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000221	0.000524	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000218	0.000518	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000208	0.000494	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000202	0.000481	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000198	0.00047	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000184	0.000437	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000184	0.000437	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000173	0.00041	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000171	0.000406	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000167	0.000397	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000164	0.000391	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000161	0.000382	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00016	0.000381	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00016	0.00038	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	0.000154	0.000367	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000153	0.000363	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00015	0.000356	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000147	0.000349	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000141	0.000334	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000138	0.000327	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000132	0.000314	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000131	0.000311	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000127	0.000301	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000123	0.000292	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000122	0.000289	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	0.000121	0.000287	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000117	0.000278	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	0.000113	0.000269	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000109	0.000259	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000109	0.000258	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000101	0.00024	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.99e-05	0.000214	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.36e-05	0.000199	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.29e-05	0.000197	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.77e-05	0.000185	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.92e-05	0.000164	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.81e-05	0.000162	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.54e-05	0.000155	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.43e-05	0.000153	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.26e-05	0.000149	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.08e-05	0.000144	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.87e-05	0.00014	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.46e-05	0.00013	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	5.15e-05	0.000122	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.44e-05	0.000105	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.12e-05	9.8e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.53e-05	8.39e-05	CbGpPWpGaD
